Sunovion Pharmaceuticals, based in Teaneck, NJ, is dedicated to improving global health by driving innovative treatments and technologies in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy. Their focus on combining technology and life sciences expertise aims to measurably enhance patient outcomes.
With a diverse pipeline spanning various modalities and indications, Sunovion Pharmaceuticals is committed to fueling breakthroughs and delivering patient-first solutions through a technology-driven approach. As a subsidiary of Sumitomo Pharma Co., Ltd., they strive to address high or unmet patient needs with speed and efficiency in drug discovery, development, and commercialization.
Generated from the website